Publications
-
Frequency of the male infertility evaluation: data from the national survey of family growth.
Eisenberg ML,
Lathi RB, Baker VL, Westphal LM, Milki AA, Nangia AK.
J Urol.
2013;
189
(3):
1030-4
-
Mild ovarian stimulation for in vitro fertilization: one perspective from the USA.
Baker VL,
J Assist Reprod Genet.
2013;
30
(2):
197-202
-
Early pregnancy testosterone after ovarian stimulation and pregnancy outcome.
Gustin SL,
Mukherjee G, Baker VL, Westphal LM, Milki AA, Lathi RB.
Fertil Steril.
2012;
97
(1):
23-7.e1
-
Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve.
Pastore LM,
Young SL, Baker VL, Karns LB, Williams CD, Silverman LM.
Reprod Sci.
2012;
19
(11):
1226-31
-
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.
Harlow SD,
Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ.
J Clin Endocrinol Metab.
2012;
97
(4):
1159-68
-
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.
Harlow SD,
Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ.
Fertil Steril.
2012;
97
(4):
843-51
-
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.
Harlow SD,
Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ.
Menopause.
2012;
19
(4):
387-95
-
Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging.
Harlow SD,
Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ.
Climacteric.
2012;
15
(2):
105-14
-
High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
Leader B,
Hegde A, Baca Q, Stone K, Lannon B, Seifer DB, Broekmans F, Baker VL.
Fertil Steril.
2012;
98
(4):
1037-42
-
Outcomes of trophectoderm biopsy on cryopreserved blastocysts: a case series.
Lathi RB,
Massie JA, Gilani M, Milki AA, Westphal LM, Baker VL, Behr B.
Reprod Biomed Online.
2012;
25
(5):
504-7
-
Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes.
Wellons MF,
Fujimoto VY, Baker VL, Barrington DS, Broomfield D, Catherino WH, Richard-Davis G, Ryan M, Thornton K, Armstrong AY.
Fertil Steril.
2012;
98
(2):
406-9
-
Age-Related Success with Elective Single versus Double Blastocyst Transfer.
Friedman BE,
Davis LB, Lathi RB, Westphal LM, Baker VL, Milki AA.
ISRN Obstet Gynecol.
2011:
2011
656204
-
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States.
Seifer DB,
Baker VL, Leader B.
Fertil Steril.
2011;
95
(2):
747-50
-
An assessment of female university students' attitudes toward screening technologies for ovarian reserve.
Bavan B,
Porzig E, Baker VL.
Fertil Steril.
2011;
96
(5):
1195-9
-
Day 2 versus day 3 embryo transfer in poor responders: a prospective randomized trial.
Shahine LK,
Milki AA, Westphal LM, Baker VL, Behr B, Lathi RB.
Fertil Steril.
2011;
95
(1):
330-2
-
Life plans and family-building options for women with primary ovarian insufficiency.
Baker V,
Semin Reprod Med.
2011;
29
(4):
362-72
-
The time is now for a new approach to primary ovarian insufficiency.
Cooper AR,
Baker VL, Sterling EW, Ryan ME, Woodruff TK, Nelson LM.
Fertil Steril.
2011;
95
(6):
1890-7
-
Use of preimplantation genetic diagnosis and preimplantation genetic screening in the United States: a Society for Assisted Reproductive Technology Writing Group paper.
Ginsburg ES,
Baker VL, Racowsky C, Wantman E, Goldfarb J, Stern JE.
Fertil Steril.
2011;
96
(4):
865-8
-
A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis.
Davis LB,
Champion SJ, Fair SO, Baker VL, Garber AM.
Fertil Steril.
2010;
93
(6):
1793-804
-
Factors affecting success rates in two concurrent clinical IVF trials: an examination of potential explanations for the difference in pregnancy rates between the United States and Europe.
Baker VL,
Jones CE, Cometti B, Hoehler F, Salle B, Urbancsek J, Soules MR.
Fertil Steril.
2010;
94
(4):
1287-91
-
Inter-laboratory validation of the measurement of follicle stimulating hormone (FSH) after various lengths of frozen storage.
Scriver J,
Baker VL, Young SL, Behr B, Pastore LM.
Reprod Biol Endocrinol.
2010:
8
145
-
Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.
Baker VL,
Luke B, Brown MB, Alvero R, Frattarelli JL, Usadi R, Grainger DA, Armstrong AY.
Fertil Steril.
2010;
94
(4):
1410-6
-
The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study.
Lewis M,
Baker V, Nezhat C.
Fertil Steril.
2010;
94
(6):
e81-2; author reply e83
-
Balancing the professional and personal.
Armstrong AY,
Alvero RJ, Dunlow S, Nace MC, Baker V, Stewart EA.
Fertil Steril.
2009;
91
(1):
18-21
-
Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL,
Fujimoto VY, Kettel LM, Adamson GD, Hoehler F, Jones CE, Soules MR.
Fertil Steril.
2009;
91
(4):
1005-11
-
Instructing an embryonic stem cell-derived oocyte fate: lessons from endogenous oogenesis.
Nicholas CR,
Chavez SL, Baker VL, Reijo Pera RA.
Endocr Rev.
2009;
30
(3):
264-83
-
Oocyte retrieval versus conversion to intrauterine insemination in patients with poor response to gonadotropin therapy.
Shahine LK,
Lathi RB, Baker VL.
Fertil Steril.
2009;
92
(4):
1315-7
-
The sex ratio of singleton offspring in assisted-conception pregnancies.
Luke B,
Brown MB, Grainger DA, Baker VL, Ginsburg E, Stern JE.
Fertil Steril.
2009;
92
(5):
1579-85
-
A new SERM on the horizon.
Baker VL,
Female Patient.
2008:
33
15-19
-
Economic cost for implementation of the U.S. Food and Drug Administration's Code of Federal Regulations Title 21, Part 1271 in an egg donor program.
Baker VL,
Gvakharia MO, Rone HM, Manalad JR, Adamson GD.
Fertil Steril.
2008;
90
(3):
537-45
-
Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing.
Baker VL,
Rone HM, Adamson GD.
Fertil Steril.
2008;
90
(6):
2091-8
-
Use of progesterone in three challenging cases.
Carson S,
Baker VL, Liu J, Wysocki S.
Sexuality, Reproduction, and Menopause.
2008:
S30-36
-
Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization.
Baker VL,
Rone HM, Pasta DJ, Nelson HP, Gvakharia M, Adamson GD.
Am J Obstet Gynecol.
2006;
194
(6):
1668-74; discussion 1674-5
-
Multiple births from assisted reproductive technologies: a challenge that must be met.
Adamson D,
Baker V.
Fertil Steril.
2004;
81
(3):
517-22, discussion 526
-
Subfertility: causes, treatment and outcome.
Adamson GD,
Baker VL.
Best Pract Res Clin Obstet Gynaecol.
2003;
17
(2):
169-85
-
Selective estrogen receptor modulators in reproductive medicine and biology.
Baker VL,
Leitman D, Jaffe RB.
Obstet Gynecol Surv.
2000;
55
(7 Suppl 2):
S21-47
-
Downregulation of protein kinase C by phorbol ester increases expression of epidermal growth factor receptors in transformed trophoblasts and amplifies human chorionic gonadotropin production.
Baker VL,
Murai JT, Taylor RN.
Placenta.
1998;
19
(7):
475-82
-
Minimum intrauterine pressure required for uterine distention.
Baker VL,
Adamson GD.
J Am Assoc Gynecol Laparosc.
1998;
5
(1):
51-3
-
Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles.
Baker VL,
Draper M, Paul S, Allerheiligen S, Glant M, Shifren J, Jaffe RB.
J Clin Endocrinol Metab.
1998;
83
(1):
6-13
-
Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors.
Baker VL,
Chao VA, Murai JT, Zaloudek CJ, Taylor RN.
J Soc Gynecol Investig.
1997 Nov-Dec;
4
(6):
316-24
-
Transvaginal reduction of an interstitial heterotopic pregnancy with preservation of the intrauterine gestation.
Baker VL,
Givens CR, Cadieux MC.
Am J Obstet Gynecol.
1997;
176
(6):
1384-5
-
Clinical uses of antiestrogens.
Baker VL,
Jaffe RB.
Obstet Gynecol Surv.
1996;
51
(1):
45-59
-
Threshold intrauterine perfusion pressures for intraperitoneal spill during hydrotubation and correlation with tubal adhesive disease.
Baker VL,
Adamson GD.
Fertil Steril.
1995;
64
(6):
1066-9
-
Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
Baker VL,
Obstet Gynecol Clin North Am.
1994;
21
(2):
271-97
-
Surrogacy: one physician's view of the role of law.
Baker VL,
Univ San Francisco Law Rev.
1994;
28
(3):
603-12
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help